![Endo Tools Therapeutics receives positive opinion from French High Authority for Health on Forfait Innovation scheme to treat patients with diabetes](https://ala.associates/wp-content/uploads/2022/06/Endo-Tools-medical-device-1080x675.jpg)
![Endo Tools Therapeutics receives positive opinion from French High Authority for Health on Forfait Innovation scheme to treat patients with diabetes](https://ala.associates/wp-content/uploads/2022/06/Endo-Tools-medical-device-1080x675.jpg)
![Hephaï appoints Armelle Roussac as head of sales](https://ala.associates/wp-content/uploads/2022/06/Armelle-Roussac-Hephai-1080x675.png)
Hephaï appoints Armelle Roussac as head of sales
![Robocath achieves positive results in R-Evolution multicenter European clinical study on robotic coronary angioplasty](https://ala.associates/wp-content/uploads/2022/05/0003_IMG_8058_ok-1080x675.jpg)
Robocath achieves positive results in R-Evolution multicenter European clinical study on robotic coronary angioplasty
![CardioRenal raises €3.3 million](https://ala.associates/wp-content/uploads/2022/03/CardioRenal-Tenor-technology-1.png)
CardioRenal raises €3.3 million
![Medtech start-up Ubiplug obtains ISO 13485:2016 certification](https://ala.associates/wp-content/uploads/2022/03/Ubiplug_Techno_2-1080x675.jpeg)
Medtech start-up Ubiplug obtains ISO 13485:2016 certification
![Carthera’s SonoCloud technology demonstrates safety and therapeutic potential in clinical trial on patients living with Alzheimer’s Disease](https://ala.associates/wp-content/uploads/2022/03/SonoCloud-Device-AD-illustration_page-0001-1080x675.jpg)
Carthera’s SonoCloud technology demonstrates safety and therapeutic potential in clinical trial on patients living with Alzheimer’s Disease
![Kayentis launches fully integrated platform for decentralized clinical trials](https://ala.associates/wp-content/uploads/2022/03/Kayentis-Clinform-solution.jpg)
Kayentis launches fully integrated platform for decentralized clinical trials
![Glooko acquiert DIABNEXT® pour élargir son offre dans le diabète en France](https://ala.associates/wp-content/uploads/2022/03/Glooko-XT-formerly-Diabnext-photo-for-press-release-1080x675.png)
Glooko acquiert DIABNEXT® pour élargir son offre dans le diabète en France
![Vygon acquires Macatt Medica, Peruvian distributor of single-use medical devices](https://ala.associates/wp-content/uploads/2022/03/Vygon-Macatt-copy-1080x675.png)
Vygon acquires Macatt Medica, Peruvian distributor of single-use medical devices
![Vygon Asia donates chemo ports to Mount Miriam Cancer Hospital for World Cancer Day](https://ala.associates/wp-content/uploads/2022/04/4-fevrier-2020-World-Cancer.png)